Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 744

1.

Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.

Wang A, Kwee LC, Grass E, Neely ML, Gregory SG, Fox KAA, Armstrong PW, White HD, Ohman EM, Roe MT, Shah SH, Chan MY.

Atherosclerosis. 2017 Mar 30;261:19-25. doi: 10.1016/j.atherosclerosis.2017.03.041. [Epub ahead of print]

PMID:
28437675
2.

Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes.

Goldstein SA, Newby LK, Cyr DD, Neely M, Lüscher TF, Brown EB, White HD, Ohman EM, Roe MT, Hamm CW.

J Am Heart Assoc. 2017 Apr 11;6(4). pii: e005334. doi: 10.1161/JAHA.116.005334.

3.

A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012.

Elliott JM, Wang TK, Gamble GD, Williams MJ, Matsis P, Troughton R, Hamer A, Devlin G, Mann S, Richards M, French JK, White HD, Ellis CJ.

N Z Med J. 2017 Apr 7;130(1453):17-28.

PMID:
28384143
4.

Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study.

Parker WA, Bhatt DL, Prats J, Day JR, Steg PG, Stone GW, Hamm CW, Mahaffey KW, Price MJ, Gibson CM, White HD, Storey RF; CHAMPION PHOENIX Investigators..

Thromb Haemost. 2017 Apr 6. doi: 10.1160/TH16-12-0958. [Epub ahead of print]

PMID:
28382371
5.

Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.

Alfredsson J, Neely B, Neely ML, Bhatt DL, Goodman SG, Tricoci P, Mahaffey KW, Cornel JH, White HD, Fox KA, Prabhakaran D, Winters KJ, Armstrong PW, Ohman EM, Roe MT; TRILOGY ACS Investigators..

Heart. 2017 Apr 5. pii: heartjnl-2016-310090. doi: 10.1136/heartjnl-2016-310090. [Epub ahead of print]

PMID:
28381584
6.

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.

Valgimigli M, Costa F, Lokhnygina Y, Clare RM, Wallentin L, Moliterno DJ, Armstrong PW, White HD, Held C, Aylward PE, Van de Werf F, Harrington RA, Mahaffey KW, Tricoci P.

Eur Heart J. 2017 Mar 14;38(11):804-810. doi: 10.1093/eurheartj/ehw525.

PMID:
28363222
7.

Is Therapeutic Hypothermia for Acute Respiratory Distress Syndrome the Future?

Hayek AJ, White HD, Ghamande S, Spradley C, Arroliga AC.

J Intensive Care Med. 2017 Jan 1:885066617701117. doi: 10.1177/0885066617701117. [Epub ahead of print]

PMID:
28343415
8.

Mediastinitis Following Endobronchial Ultrasound-guided Transbronchial Needle Aspiration.

Jahoor A, Ghamande S, Jones S, Boethel C, White HD.

J Bronchology Interv Pulmonol. 2017 Feb 10. doi: 10.1097/LBR.0000000000000370. [Epub ahead of print]

PMID:
28195963
9.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators..

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

PMID:
28081827
10.

High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial.

Eisen A, Bonaca MP, Jarolim P, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KA, Bohula EA, Murphy SA, Braunwald E, Morrow DA.

Clin Chem. 2017 Jan;63(1):307-315. doi: 10.1373/clinchem.2016.264788. Epub 2016 Nov 8.

PMID:
28062625
11.

Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention.

Sawlani NN, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL.

Circ Cardiovasc Interv. 2017 Jan;10(1). pii: e004380. doi: 10.1161/CIRCINTERVENTIONS.116.004380.

PMID:
28039321
12.

Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL.

JAMA Cardiol. 2017 Feb 1;2(2):127-135. doi: 10.1001/jamacardio.2016.4556.

PMID:
27902833
13.

State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease.

Omland T, White HD.

Clin Chem. 2017 Jan;63(1):165-176. doi: 10.1373/clinchem.2016.255190. Epub 2016 Nov 4. Review.

PMID:
27815307
14.

Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

Cornel JH, Ohman EM, Neely B, Jakubowski JA, Bhatt DL, White HD, Ardissino D, Fox KA, Prabhakaran D, Armstrong PW, Erlinge D, Tantry US, Gurbel PA, Roe MT.

J Am Heart Assoc. 2016 Nov 4;5(11). pii: e003977.

15.

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.

Hagström E, Held C, Stewart RA, Aylward PE, Budaj A, Cannon CP, Koenig W, Krug-Gourley S, Mohler ER 3rd, Steg PG, Tarka E, Östlund O, White HD, Siegbahn A, Wallentin L; STABILITY Investigators..

Clin Chem. 2017 Jan;63(1):325-333. doi: 10.1373/clinchem.2016.260570. Epub 2016 Nov 3.

PMID:
27811204
16.

Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure).

Petrie MC, Jhund PS, She L, Adlbrecht C, Doenst T, Panza JA, Hill JA, Lee KL, Rouleau JL, Prior DL, Ali IS, Maddury J, Golba KS, White HD, Carson P, Chrzanowski L, Romanov A, Miller AB, Velazquez EJ; STICH Trial Investigators..

Circulation. 2016 Nov 1;134(18):1314-1324. Epub 2016 Aug 29.

PMID:
27573034
17.

Clinical Utility of Testing for Legionella Pneumonia in Central Texas.

Henry C, Boethel C, Copeland LA, Ghamande S, Arroliga AC, White HD.

Ann Am Thorac Soc. 2017 Jan;14(1):65-69. doi: 10.1513/AnnalsATS.201606-501BC.

PMID:
27739904
18.

Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.

Abtan J, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm CW, Price MJ, Abnousi F, Prats J, Deliargyris EN, White HD, Harrington RA, Bhatt DL; CHAMPION PHOENIX Investigators..

JACC Cardiovasc Interv. 2016 Sep 26;9(18):1905-13. doi: 10.1016/j.jcin.2016.06.046.

PMID:
27659566
19.

"Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: CHAMPION PHOENIX Findings.

Selvaraj S, Bhatt DL, Stone GW, Gibson CM, Steg PG, Hamm CW, Price MJ, Deliargyris EN, Prats J, Mahaffey KW, White HD, Harrington RA; CHAMPION PHOENIX Investigators..

J Am Coll Cardiol. 2016 Nov 29;68(21):2385-2387. doi: 10.1016/j.jacc.2016.08.023. Epub 2016 Aug 30. No abstract available.

PMID:
27591042
20.

Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial.

Adamo M, Ariotti S, Costa F, Curello S, Moschovitis A, de Vries T, White HD, Windecker S, Valgimigli M.

JACC Cardiovasc Interv. 2016 Aug 22;9(16):1667-76. doi: 10.1016/j.jcin.2016.05.031.

PMID:
27539685

Supplemental Content

Loading ...
Support Center